Chemoinformaics analysis of Oxacyclooctadecan-2-one
| Molecular Weight | 268.441 | nRot | 0 |
| Heavy Atom Molecular Weight | 236.185 | nRig | 27 |
| Exact Molecular Weight | 268.24 | nRing | 1 |
| Solubility: LogS | -3.641 | nHRing | 1 |
| Solubility: LogP | 1.864 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 51.3314 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.187 |
| Synth | 6.335 |
| Natural Product Likeliness | 2.926 |
| NR-PPAR-gamma | 0.625 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.973 |
| HIA | 0.867 |
| CACO-2 | -5.272 |
| MDCK | 0.0000924 |
| BBB | 0.44 |
| PPB | 0.30443 |
| VDSS | 1.212 |
| FU | 0.470988 |
| CYP1A2-inh | 0.002 |
| CYP1A2-sub | 0.058 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.503 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.016 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.061 |
| CYP3a4-inh | 0.62 |
| CYP3a4-sub | 0.567 |
| CL | 2.98 |
| T12 | 0.089 |
| hERG | 0.024 |
| Ames | 0.071 |
| ROA | 0.931 |
| SkinSen | 0.014 |
| Carcinogencity | 0.962 |
| EI | 0.012 |
| Respiratory | 0.073 |
| NR-Aromatase | 0.749 |
| Antiviral | Yes |
| Prediction | 0.626856 |